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Epigallocatechin-3-gallate (EGCG) is a major component of green tea polyphenols which displays
potential properties of anticancer and neuroprotection. Here we show that protection of motor neu-
ron by EGCG is associated with regulating glutamate level in organotypic culture of rat spinal cord.
In this model, EGCG blocked glutamate excitotoxicity caused by threohydroxyaspartate, an inhibitor
of glutamate transporter. This property of EGCG may be not due to its intrinsic antioxidative activity,
because another antioxidant could not regulate glutamate level under the same condition. These
results show that EGCG may be a potential therapeutic candidate for neurodegenerative diseases
involving glutamate excitotoxicity such as ALS.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Green tea is a popular worldwide beverage. The green tea
polyphenols (GTPs) consist of four main components: ()-epigallo-
catechin gallate (EGCG), ()-epicatechin gallate (ECG), ()-epigal-
locatechin (EGC), and ()-epicatechin (EC) [1]. EGCG is the major
constituent, accounting for more than 10% of the extract in dry
weight. EGCG is not only a natural anticancer agent, but also a neu-
roprotective candidate [2]. It is reported that EGCG has multifunc-
tional therapeutic effects in mouse model of amyotrophic lateral
sclerosis (ALS) [3,4]. It has been found that EGCG protects neurons
via many mechanisms: scavenging free radical, chelating transi-
tional metals, modulation of cell survival/death genes and cell sig-
nal transduction pathways, and induction of phase II drug
metabolizing enzymes [2,5].chemical Societies. Published by E
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ndong 276000, China.Threohydroxyaspartate (THA) is an inhibitor of glutamate
transport and causes glutamate excitotoxicity in organotypic cul-
ture of rat spinal cord as a result of blockage of glutamate uptake
and ensuring accumulation of extracellular glutamate [6]. THA-in-
duced motor neuron death in organotypic culture of rat spinal cord
has been a widely used model of ALS and was also used for identi-
ﬁcation of agents that provide neuroprotection by increasing gluta-
mate transporter expression [7]. Here we investigated effects of
EGCG on motor neurons in organotypic culture of rat spinal cord.
2. Materials and methods
2.1. Materials
EGCG was purchased from LKT Laboratories (St. Paul, MN). N-
acetyl-L-cysteine (NAC) and THA was purchased from Sigma (St.
Louis, MO). Antibodies recognizing neuroﬁlament (SMI-32) was
purchased from Sternberger Monoclonals (Lutherville, MD). Anti-
bodies recognizing excitatory amino acid transporter 2 (EAAT2)
and b-actin were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA).
2.2. Organotypic culture of rat spinal cord
Experiments have been conducted in accordance with the Na-
tional Institutes of Health Guide for the Care and Use of Laboratorylsevier B.V. All rights reserved.
2922 J. Yu et al. / FEBS Letters 584 (2010) 2921–2925Animals and were accepted by the local animal care committee.
Organotypic spinal cord cultures were prepared as described previ-
ously [6]. Brieﬂy, lumbar spinal cords were removed from 6 to
8 days old Sprague Dawley rats (Animal Center of Hebei Medical
University) under sterile conditions. Nerve roots and excessive tis-
sues were removed in sterile Gey’s balanced salt solution contain-
ing 6.4 mg/ml glucose. Spinal cords were then sectioned
transversely at 350-lm intervals using a tissue chopper (Mickle
Laboratory Engineering, Surrey, UK). The tissue slices were placed
on the surface of 30-mm Millipore Millicell-CM membrane inserts
(Bedford, MA), ﬁve slices/insert. The inserts were placed in a six-
well culture plate containing 1 ml of culture medium consisting
of 50% minimal essential medium, 25% heat-inactivated horse ser-
um, 25% Hanks’ balanced salt solution (supplemented with
25.6 mg/ml D-glucose and 2 mM glutamine). The cultures wereFig. 1. THA-induced neuronal damage and the effect of EGCG on the motor neurons. Rat
The medium was changed twice each week. For combination treatment of THA with EGCG
then switched to the combination of THA (100 lM) and EGCG for 3 weeks. The exp
immunostaining of explants with SMI-32, showing motor neurons in the ventral horns o
per explant in each experiment group (means ± S.D., n = 10–15). (C) Effect of EGCG on i
explants. * Different from the control and ** different from THA-only group (P < 0.05).maintained at 37 C in a humidiﬁed incubator with 5% CO2 for up
to 4 weeks. Culture media along with test chemicals were changed
biweekly, unless speciﬁed otherwise. THA and NAC were dissolved
in water. EGCG was dissolved in DMSO. The ﬁnal concentration of
DMSO was 0.1% in culture medium, and this amount has no effect
on the motor neurons in our culture (our previous data).
2.3. Treatments on organotypic cultures
Unless otherwise stated, the spinal cord explants were cultured
in vitro for 7 days. On day 7, the explants were pretreated with
EGCG (or NAC) for 48 h, and then treated with the combination
of EGCG (or NAC) and THA for 3 weeks. The culture medium along
with test chemicals was replaced twice a week. At the end of the 3-
week treatment, the explants and media were harvested for test.spinal cord explants were treated with either vehicle or THA at 100 lM for 3 weeks.
, the explants were ﬁrst treated with EGCG at 1, 5, 10, 20, 50 or 100 lM for 48 h and
lants were harvested at the end of the treatment. (A) Representative images of
f three experimental groups (scale bar = 100 lm). (B) The number of motor neurons
nhibition of glutamate uptake by THA. (D) Formation of lipid peroxides (TBARS) in
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For the visualizing of motor neurons in spinal cord explants, the
cultures, at the end of an experimental treatment, were ﬁxed with
4% paraformaldehyde in 0.1 M phosphate buffer (PB) (pH 7.4) and
then rinsed three times with 0.1 M PB. The explants were washed
in Tris-buffered saline (TBS) for 30 min and then treated with 10%
horse serum for 1 h at room temperature. The explants were subse-
quently stained overnight at 4 Cwith SMI-32monoclonal antibody
diluted in TBS containing 0.5% Triton X-100, which was followed by
three-time washing with TBS-T and incubation with a biotinylated
secondary antibody for 1 h. The explants were further washed and
then incubated with a horseradish peroxidase-conjugated ABC
staining solution (Vector Laboratories, Burlingame, CA). The ex-
plants were ﬁnally mounted on glass slides, and motor neurons in
the ventral horns,whichwere staineddarkbrown,were countedun-Fig. 2. THA-induced neuronal damage and the effect of NAC on the motor neurons. Rat s
The medium was changed twice each week. For combination treatment of THA with NAC
the combination of THA (100 lM) and NAC for 3 weeks. The explants were harvested at
with SMI-32, showing motor neurons in the ventral horns of three experimental gro
experiment group (means ± S.D., n = 10–15). (C) Effect of NAC on inhibition of glutamate u
the control and ** different from THA-only group (P < 0.05).der a lightmicroscope. The representative imageswere fromventral
horn of explants, and we counted all motor neurons in both ventral
horns per explant. This is similar towhatwe reported previously [8].
2.5. Western blot analysis
The spinal cord explants at the end of an experimental treat-
ment were processed to prepare whole tissue extracts, using tissue
extraction reagents kit (Applygen Technologies Inc., China). The ex-
tracts were separated by SDS–PAGE and transferred to PVDF mem-
branes. The speciﬁc primary antibodies were used to probe the
speciﬁc protein in the membranes, and then followed with a ﬂuo-
rescent secondary antibody. Finally, the interesting bands were de-
tected using an Odyssey Infrared Imaging System (LI-COR, Lincoln,
NE). The usual green or red color of a band was converted to black
and white colors for data presentation.pinal cord explants were treated with either vehicle or THA at 100 lM for 3 weeks.
, the explants were ﬁrst treated with NAC at 100 lM for 48 h and then switched to
the end of the treatment. (A) Representative images of immunostaining of explants
ups (scale bar = 100 lm). (B) The number of motor neurons per explant in each
ptake by THA. (D) Formation of lipid peroxides (TBARS) in explants. * Different from
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Levels of lipid peroxidation were quantiﬁed by using the thio-
barbituric acid-reactive substances (TBARS) assay kit (Jian Cheng
Biological Engineering Institute, Nanjing, China) according to the
manufacturer’s instructions. The principle is that lipid peroxidation
products, including malondialdehyde and hydroperoxides, react
with thiobarbituric acid to produce a red product that can be sen-
sitively measured spectroscopically. The absorbance at 532 nm
was determined using a Synergy HT Microplate Reader (BioTek
Instruments, Winooski, VT).
2.7. Measurement of glutamate in culture medium
Glutamate concentrations in culture medium were assayed
using a glutamate detection kit (Jian Cheng Biological Engineering
Institute, Nanjing, China). This method is based on the conversion
of glutamate to a-ketoglutarate catalyzed by glutamic dehydroge-
nase with concomitant conversion of NAD+ to NADH [9].
2.8. Statistical analysis
Results are expressed as means ± S.D. Statistical analyses were
performed using one-way ANOVA followed by Student’s t-test. Dif-
ferences were considered signiﬁcant at P < 0.05.Fig. 3. Effect of EGCG on expression of EAAT2 in explants of rat spinal cord. (A) The
rat spinal cord explants were pretreated with EGCG at 5 lM for 48 h, and then
harvested for western blot to measure the tissue expression level of EAAT2. (B) For
combination treatment of THA with EGCG, the explants were ﬁrst treated with
EGCG at 5 lM for 48 h and then switched to the combination of THA (100 lM) and
EGCG for 3 weeks. The explants were harvested for western blot at the end of the
treatment. The immunoblotting data are representative of at least three experi-
ments (10–15 explants were pooled in each experiment). b-Actin was used as a
loading control. Data were expressed as levels of immunoreactivity relative to
control values (means ± S.D., n = 4).3. Results
3.1. EGCG protected motor neurons against THA-induced toxicity
Rat lumbar spinal cord explants, after one week in culture, were
pretreated with EGCG at 0, 1, 5, 10, 20, 50 and 100 lM for 48 h and
then treated with the combination of EGCG at the same concentra-
tions and THA at 100 lM for 3 weeks. The culture medium was re-
placed with an equal volume of freshly prepared medium
containing the same concentrations of EGCG and THA twice per
week. The control group of explants was treated with the vehicle
only. At the end of the 3-week treatment, the explants were har-
vested and immunostained with the anti-neuroﬁlament antibody
SMI-32 for visualization and counting of motor neurons. The repre-
sentative images of ventral horn neurons of explants treated with
vehicle, 100 lM THA, and 5 lM EGCG plus 100 lM THA are shown
in Fig. 1A. We counted all motor neurons in both ventral horns per
explant, and each experiment group had 10 explants. There were
22.5 ± 2.70 (mean ± S.D.) motor neurons per explant in the control
group, but only 5 ± 0.71 motor neurons per explant after THA treat-
ment, a 78% decrease (Fig. 1B). This ﬁnding is similar to those re-
ported previously [6,8,10]. The number of motor neurons
(26 ± 4.34) per explant was even higher in explants treated with
5 lM EGCG plus 100 lM THA than in the control (Fig. 1B), showing
that EGCG completely blocked THA-induced motor neuron death.
Interestingly, EGCG prevented THA-induced neuron death at low
concentration, but high concentration of EGCG would be toxic to
motor neurons (Fig. 1B).
3.2. Effect of EGCG on glutamate transport
Since THA-induced neuronal toxicity in spinal cord explants is
known to result from inhibition of glutamate uptake, it was impor-
tant to measure medium glutamate in EGCG-treated cultures. As
shown in Fig. 1C, after treatment of rat spinal cord explants with
THA at 100 lM for 3 weeks, medium glutamate level increased
2.75 fold, which is similar to previous data [6,8,10]. Interestingly,
the medium glutamate level was signiﬁcantly lower in cultures re-
ceived the joint treatment 100 lM THA and 5 lM EGCG after3 weeks than that received THA treatment alone (Fig. 1C). Mean-
while, we treated explants with another antioxidant, NAC, in order
to learn whether the antioxidants can regulate the glutamate level.
As shown in Fig. 2A and B, 100 lM NAC could block THA-induced
motor neuron death, but had no effect on culture medium gluta-
mate (Fig. 2C).
Furthermore, we assayed the expression of the EAAT2. EAAT2 is
a high afﬁnity, Na+-dependent glutamate transporter of glial origin
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mate and prevention of excitotoxicity. There was no change of
EAAT2 expression after treatment with 5 lM EGCG for 48 h
(Fig. 3A). Unexpectedly, after treatment with 100 lM THA for
3 weeks, the expression levels of EAAT2 was higher than control,
while after the joint treatment of 5 lM EGCG and 100 lM THA
for 3 weeks, the expression levels of EAAT2 was lower than that
treated with THA-only (Fig. 3B).
3.3. Effect of EGCG on lipid peroxidation
We also measured tissue level of lipid peroxides (TBARS). TBARS
is a marker of overall lipid peroxidation. At the end of 3-week
treatment, the spinal cord explants were harvested for measure-
ment of TBARS. The concentration of TBARS was 1.27 ± 0.38
nmol/mg protein in the control explants, while THA treatment sig-
niﬁcantly increased the levels of tissue TBARS (4.58 ± 0.46 nmol/
mg protein). EGCG prevented the effects of THA and decreased
the TBARS to 1.95 ± 1.16 nmol/mg protein (Fig. 1D). While NAC
has the same effect on lipid peroxidation as EGCG, it can decrease
TBARS that caused by THA (Fig. 2D).
4. Discussion
In ALS, glutamate-mediated neurotoxicity was ﬁrst suggested as
a mechanism of motor neuron death. Increased levels of glutamate
were detected in the cerebrospinal ﬂuids of 40% of sporadic ALS pa-
tients [11]. THA-induced glutamate excitotoxicity in organotypic
spinal cord cultures has been one of the widely used models of mo-
tor neuron degeneration and has also been applied for develop-
ment of neuroprotective strategies [12]. In the present study, we
found that motor neuron protection by EGCG was accompanied
by regulation of glutamate levels in the synaptic cleft, and there
have been few studies investigating this mechanism of EGCG.
Interestingly, the medium glutamate level after treatment with
5 lM EGCG plus 100 lM THA was markedly lower than that in the
THA group at the end of 3 weeks of experiment, but the expression
level of EAAT2, the essential protein for the clearance of synaptic-
ally released glutamate, was lower in the EGCG plus THA group
than in the THA-only group. An increase in EAAT2 expression pos-
sibly represented an attempt to prevent the excitotoxic damage
known to be operative in the THA treated explants. It is reported
that another component of GTPs, ()-epicatechin-3-gallate (ECG),
could bring a signiﬁcant improvement in glutamate uptake in C6
cells [13]. Moreover, our results indicated that the effect of EGCG
on glutamate might not result from its antioxidative activity, be-
cause similar antioxidant NAC could not regulate glutamate level
under the same experimental conditions. We speculate that EGCG
could increase the activity of EAAT2 and the glutamate uptake of
astrocyte, so the medium glutamate levels decreased after treat-
ment with EGCG for 3 weeks.
Glutamate excitotoxicity is thought to result mainly from ex-
cess calcium entry into neurons triggered by over-stimulation of
postsynaptic glutamate receptors [14]. A large rise in intracellular
Ca2+ levels in these cells causes rapid mitochondrial calcium over-
load, leading to mitochondrial damage and generation of reactive
oxygen species [15,16]. Our results show that EGCG treatment of
the spinal cord tissues could decrease tissue TBARS levels. This sug-gests that EGCG may inhibit lipid peroxidation via decreasing glu-
tamate levels.
In summary, EGCG can protect motor neurons and regulate glu-
tamate levels in organotypic culture of rat spinal cord. In view of
the importance of glutamate excitotoxicity in ALS, EGCG may be
a potential candidate for ALS therapy.
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